This products is free for those who attended FNCE® 2019.
Emerging research seems to indicate a connection between insulin resistance in the brain and the development of Alzheimer's disease--a condition researchers are calling type-3 diabetes. Suzanne de la Monte, MD, MPH is the leading expert in this developing field. In this interview, Dr. de la Monte will discuss her research detailing the links between brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. The conversation will also review the clinical and experimental data linking chronic hyperinsulinaemia to cognitive impairment and neurodegeneration. Dr. de la Monte will share opportunities to discover and implement new treatments and devise preventive measures.
Planned with the Committee for Lifelong Learning
CPE Level: 1- Intermediate
Learning Need Codes: 5190, 5300, 4040
- 8.1.5 Applies medical nutrition therapy in disease prevention and management.
- 8.3.6 Keeps abreast of current nutrition and dietetics knowledge and trends.
- 8.1.4 Demonstrates knowledge of nutrient requirements throughout the life span and their role in health promotion and disease management.
- Describe the characteristics, symptoms and diagnosis of Type 3 Diabetes
- Identify the hypothesis and research in the development and treatment of Type 3 Diabetes
- Summarize the current medical nutrition therapy implications of Type 3 Diabetes
- Anne Davis, PhD, RDN, FAND
- Suzanne de la Monte, MD, MPH